FR1559102A - - Google Patents

Info

Publication number
FR1559102A
FR1559102A FR1559102DA FR1559102A FR 1559102 A FR1559102 A FR 1559102A FR 1559102D A FR1559102D A FR 1559102DA FR 1559102 A FR1559102 A FR 1559102A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1559102A publication Critical patent/FR1559102A/fr
Expired legal-status Critical Current

Links

FR1559102D 1968-01-23 1968-01-23 Expired FR1559102A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR137150 1968-01-23

Publications (1)

Publication Number Publication Date
FR1559102A true FR1559102A (pt) 1969-03-07

Family

ID=8644994

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1559102D Expired FR1559102A (pt) 1968-01-23 1968-01-23

Country Status (1)

Country Link
FR (1) FR1559102A (pt)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019070677A1 (en) * 2017-10-02 2019-04-11 The Procter & Gamble Company METHODS OF INHIBITING CONVERSION FROM CHOLINE TO TRIMETHYLAMINE (TMA)
US10751301B2 (en) 2017-10-02 2020-08-25 The Procter & Gamble Company Methods for inhibiting conversion of choline to trimethylamine (TMA)
US10849866B2 (en) 2017-10-02 2020-12-01 The Procter & Gamble Company Methods for inhibiting conversion of choline to trimethylamine (TMA)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019070677A1 (en) * 2017-10-02 2019-04-11 The Procter & Gamble Company METHODS OF INHIBITING CONVERSION FROM CHOLINE TO TRIMETHYLAMINE (TMA)
CN111163765A (zh) * 2017-10-02 2020-05-15 宝洁公司 用于抑制胆碱向三甲胺(tma)的转化的方法
US10675256B2 (en) 2017-10-02 2020-06-09 The Procter & Gamble Company Methods for inhibiting conversion of choline to trimethylamine (TMA)
US10751301B2 (en) 2017-10-02 2020-08-25 The Procter & Gamble Company Methods for inhibiting conversion of choline to trimethylamine (TMA)
US10849866B2 (en) 2017-10-02 2020-12-01 The Procter & Gamble Company Methods for inhibiting conversion of choline to trimethylamine (TMA)
AU2018345748B2 (en) * 2017-10-02 2021-03-18 The Cleveland Clinic Foundation Methods for inhibiting conversion of choline to trimethylamine (TMA)
CN111163765B (zh) * 2017-10-02 2023-05-09 宝洁公司 用于抑制胆碱向三甲胺(tma)的转化的方法

Similar Documents

Publication Publication Date Title
AU1946070A (pt)
AU428130B2 (pt)
AU2374870A (pt)
FR1559102A (pt)
AU416157B2 (pt)
AU429879B2 (pt)
AU2581067A (pt)
AU421558B1 (pt)
AU4744468A (pt)
AR203075Q (pt)
AU3224368A (pt)
AU2580267A (pt)
AU3789668A (pt)
BE709496A (pt)
AU2496167A (pt)
BE723332A (pt)
AU3083868A (pt)
BE722733A (pt)
BE713551A (pt)
BE725939A (pt)
AU2889368A (pt)
BE726677A (pt)
BE726758A (pt)
BE709484A (pt)
BE709479A (pt)

Legal Events

Date Code Title Description
ST Notification of lapse